arrow
M

Mauro Viganò

ASST Papa Giovanni XXIII
H指数:35
被引数:5,410

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

AISF practice guidance on the treatment of primary biliary cholangitis: A 2026 update

国际自身免疫性肝病研究基金会关于原发性胆汁性胆管炎治疗指南:2026年更新

2026-08-010
PRE
Baseline HDV-RNA Levels Could Stratify Clinical Risk Before, But Not After, Cirrhosis in Chronic Hepatitis D: A Multicentre European Study

基线HDV-RNA水平可在肝硬化前但不在肝硬化后分层临床风险:一项多中心欧洲研究

2026-04-200
PRE
RETREAT Score Accurately Predicts the Long-Term Risk of HCC Recurrence After Liver Transplantation: A Single-Center Real-Life Validation

RETREAT评分可准确预测肝移植后肝癌复发的长期风险:一项单中心真实世界验证研究

Cancers
IF4.4
2026-02-090
OAAI
Clinical Features, Management and Prognosis of Hepatic Sarcoidosis: Insights From a Nationwide Italian Study

肝肉芽肿病的临床特征、治疗与管理及预后:来自一项全国性意大利研究的见解

2025-12-010
PRE
Management of Hepatitis B virus infection in patients on treatment with immunosuppressants or immunomodulators: Position Paper of Associazione Italiana Studio del Fegato (AISF), Associazione Italiana di Oncologia Medica (AIOM), Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO), Società Italiana di Reumatologia (SIR), Società Italiana Trapianti d'Organo (SITO), Società Italiana di Gastroenterologia (SIGE), Società Italiana di Malattie Infettive e Tropicali (SIMIT)

乙型肝炎病毒感染的管理:意大利肝病研究协会(AISF)、意大利医学肿瘤学会(AIOM)、意大利骨髓移植小组(GITMO)、意大利风湿病学会(SIR)、意大利器官移植学会(SITO)、意大利胃肠病学学会(SIGE)、意大利感染病与热带病学会(SIMIT)立场文件

2025-11-100
PRE
Diagnosed Patients With Chronic Hepatitis B and Delta Virus in Italy in 2024: An Estimation From a National Real-World Database

2024年意大利慢性乙型肝炎和德尔塔病毒诊断患者的估计:基于国家真实世界数据库的研究

2025-09-040
OAAI
Hepatitis B Immunoglobulins Withdrawal in Hepatitis B Virus Mono-Infected Liver Transplant Recipients: An Italian Multicentre Prospective Study

乙型肝炎免疫球蛋白停用在乙型肝炎病毒单感染肝移植受者中的研究:一项意大利多中心前瞻性研究

2025-08-270
OAAI
The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian Paradigm

乙型肝炎病毒感染对原住民和移民的医疗影响:意大利范例

2025-07-290
OAAI
Risk factors of metabolic dysfunction-associated steatotic liver disease in a cohort of patients with chronic hepatitis B

代谢功能障碍相关脂肪性肝病在慢性乙型肝炎患者队列中的危险因素

2025-07-020
OAAI
Key Predictors of Relevant Weight Loss in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

代谢功能障碍相关脂肪性肝病患者的显著减肥关键预测因子

2025-06-040
OAAI
Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study
2025-02-120
OAAI
Long-term Bulevirtide monotherapy in patients with HDVrelated compensated cirrhosis: effectiveness, safety and clinical outcomes from the retrospective multicenter european study (Save-D)
2025-02-010
PRE
The impact of first and further decompensation in patients with metabolic-dysfunction associated compensated advanced chronic liver disease
2025-02-010
PRE